InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Henderson Jeffrey William, Director. Director active across 4 companies, notably Halozyme Therapeutics, INC.. In total, 9 filings have been logged. The latest transaction was filed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations9 total
015,777 shares0
Common Stock
SEC:0001209191-22-038613:0·
06,206 shares0
Restricted Stock Units
SEC:0001179110-22-002909:0·
04,559 shares0
Common Stock
SEC:0001888316-22-000022:0·
0820 shares0
Common Stock
SEC:0001062993-22-001583·
0820 shares0
Common Stock
SEC:0001062993-22-001583:0·
04,700 shares0
Common Stock
SEC:0001209191-21-036677:0·
04,700 shares0
Common Stock
SEC:0001209191-21-036677·
05,230 shares0
Restricted Stock Units
SEC:0001179110-21-004972:0·
5,230 shares
Restricted Stock Units
SEC:0001179110-21-004972·
9 of 9 declarations
About Henderson Jeffrey William
Henderson Jeffrey William is a Director at Halozyme Therapeutics, Inc., FibroGen Inc, and Becton Dickinson & Co. As a board member, he plays a key role in overseeing the activities of these companies and strategic decision-making. His expertise is essential in ensuring good governance and supporting the growth of these organizations.
